11:22 AM
 | 
May 25, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on May 24 with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through commercialization and market access.

Arch, 6 Dimensions Capital and Boyu Capital led the round. Yunfeng Capital, Sequoia Capital and Blue Pool Capital also participated.

The company is focused initially on...

Read the full 305 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >